Biomet Receives FDA Clearance for Articulation E1 Hip System

Biomet, a device company focused on the manufacturing of orthopedic products, has received FDA clearance for its Active Articulation E1 Dual Mobility Hip System, according to a company news release.

Advertisement

The Active Articulation Hip System merges the concept of dual mobility with Biomet’s exclusive E1 Antioxidant Infused technology and a proven cup design. The dual mobility hip concept utilizes a small femoral head that articulates within polyethylene. The large polyethylene bearing, when triggered, acts as a large head bearing that articulates within a metal cup.

Read the company news release about FDA approval of Biomet’s Active Articulation Hip System (pdf).

Related Articles on Biomet:
Biomet Co-Founder Recognized as Entrepreneurial Leader
Biomet Acquires Massachusetts’ Cytosol Laboratories
Biomet Increases Net Sales by 2% During 1Q FY 2011, Less Than Expected

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.